Synthetic Biology Market Poised for Exponential Growth to USD 67.47 Billion by 2033, Driven by Genome Engineering Advances and Industrial Biomanufacturing Demand | DataM Intelligence

The global Synthetic Biology Market reached US$ 12.37 Billion in 2024 and is expected to surge to US$ 67.47 Billion by 2033, growing at a robust CAGR of 20.9% during the forecast period 2025-2033. This rapid expansion is driven by breakthroughs in genome engineering, declining DNA synthesis and sequencing costs, increasing adoption of bio-based manufacturing, and rising demand for sustainable solutions across healthcare, agriculture, food, and industrial sectors.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/synthetic-biology-market?jd

Global Key Industry Developments
The synthetic biology ecosystem is evolving rapidly with strong investments in automation, AI-driven bioinformatics, and scalable biomanufacturing platforms.
✅ November 2025: Leading biotech firms are expected to expand AI-powered genome design and biofoundry platforms to accelerate strain development for pharmaceuticals, enzymes, and sustainable chemicals.
✅ October 2025: Several global players are projected to scale up synthetic DNA and enzyme production facilities to meet rising demand from industrial biotechnology and precision medicine applications.
✅ September 2025: Academic-industry collaborations are anticipated to intensify, focusing on synthetic cells and xeno-nucleic acids for next-generation therapeutics and advanced biological systems.

Key Mergers and Acquisitions (2025):
✅ Platform Expansion and Technology Consolidation: In 2025, synthetic biology companies are actively pursuing acquisitions of bioinformatics, genome engineering, and automation startups to strengthen end-to-end design-build-test-learn (DBTL) capabilities and accelerate commercialization.

Market Segmentation Analysis
-By Product Type: Synthetic DNA and Enzymes Lead Market Adoption
Oligonucleotides and Synthetic DNA represent a dominant segment, driven by their critical role in genome editing, diagnostics, and therapeutic development. Enzymes are witnessing strong demand across industrial processing, pharmaceuticals, and food applications. Emerging segments such as Synthetic Cells and Xeno-Nucleic Acids are gaining attention for their potential in advanced therapeutics and novel biological systems.

-By Technology: Genome Engineering and Bioinformatics Drive Innovation
Genome Engineering technologies dominate the market, supported by widespread adoption of CRISPR and advanced gene-editing platforms. Bioinformatics is a high-growth segment, enabling AI-driven design, modeling, and optimization of complex biological systems. Sequencing and cloning technologies continue to underpin innovation across research and commercial applications.

-By Application: Medical and Industrial Applications Lead Growth
Medical Applications account for a significant share, supported by rising use in gene therapies, vaccines, and precision medicine. Industrial Applications are expanding rapidly as companies adopt synthetic biology for sustainable chemicals, biofuels, and enzyme-based manufacturing. Food, animal health, and agricultural applications are also gaining momentum due to demand for resilient crops, alternative proteins, and feed additives.

-By End-User: Pharma & Biotech Companies Dominate Demand
Pharmaceutical and Biotechnology Companies are the largest end-users, driven by strong R&D investments and commercialization of synthetic biology-enabled therapeutics. Industrial and chemical companies are rapidly increasing adoption to replace petrochemical processes with bio-based alternatives.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=synthetic-biology-market
(Purchase 2 or more Reports and get 50% Discount)

Regional Insights
North America dominates the Synthetic Biology Market, accounting for the largest revenue share of 43.14% in 2024. The region benefits from strong venture capital funding, advanced research infrastructure, early adoption of genome engineering technologies, and the presence of leading biotech companies and academic institutions. Asia-Pacific is the fastest-growing region and is expected to register the highest CAGR of 21.1% during the forecast period. Growth is driven by expanding biotechnology manufacturing capacity, increasing government support for bioeconomy initiatives, rising investments in genomics and bioinformatics, and rapid industrial adoption in countries such as China, Japan, South Korea, and India. Europe continues to show steady growth, supported by sustainability-driven policies, industrial biotechnology adoption, and strong academic research networks.

Growth Drivers:
1. Rapid Advancements in Genome Engineering Technologies: Innovations such as CRISPR and synthetic DNA synthesis are accelerating product development and commercialization.
2. Rising Demand for Sustainable and Bio-Based Manufacturing: Industries are increasingly adopting synthetic biology to reduce carbon footprint and reliance on fossil fuels.
3. Expansion of Precision Medicine and Gene Therapies: Growing focus on personalized healthcare is driving medical applications of synthetic biology.
4. Declining Costs of DNA Sequencing and Synthesis: Cost reductions are enabling broader adoption across research and commercial sectors.
5. Strong Public and Private Investments: Government funding, venture capital, and strategic partnerships are fueling ecosystem growth globally.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/synthetic-biology-market?jd

Key Players:
The major players in the Synthetic Biology Market include Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc., Bota Biosciences, Codexis, Inc., Twist Bioscience, Creative Biogene, and Eurofins Genomics, among others.
Key Highlights (Top 5 Key Players):
1. Thermo Fisher Scientific Inc. offers comprehensive synthetic biology workflows, including DNA synthesis, sequencing, and analytical tools, supporting both research and commercial-scale applications.
2. Illumina, Inc. plays a critical role in next-generation sequencing technologies that enable rapid genome analysis and synthetic biology innovation.
3. Merck KGaA provides advanced genome editing tools, enzymes, and bioinformatics solutions for research and industrial biotechnology.
4. Twist Bioscience specializes in high-throughput synthetic DNA manufacturing, enabling scalable and cost-effective genome engineering.
5. Codexis, Inc. focuses on enzyme engineering platforms that support sustainable industrial and pharmaceutical manufacturing.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply-Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.